Key Dates

Related Announcements

• March 2, 2021 - Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required). See PAR-21-130
• March 2, 2021 - Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required). See PAR-21-131
• March 2, 2021 - Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required). See PAR-21-132
• March 2, 2021 - First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required). See PAR-21-133 
• March 2, 2021 - Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). See PAR-21-134 
• March 2, 2021 - Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required). See PAR-21-135
• March 2, 2021 - Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required). See PAR-21-136
• March 2, 2021 - Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required). See PAR-21-137

Issued by

National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to extend the expiration dates for the following PARs: 

PAR-21-130, Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
PAR-21-131, Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required)
PAR-21-132, Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
PAR-21-133, First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)
PAR-21-134, Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
PAR-21-135, Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
PAR-21-136, Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
PAR-21-137, Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Due to the extension, the following application due date will be added: June 15, 2024, and October 15, 2024.

The following sections in Part 1. Overview Information, Key Dates section have been changed:  

Currently reads:

Expiration Date: February 16, 2024 

Modified to read :

New Expiration Date: October 16, 2024.

All other aspects of these NOFOs remain unchanged.

Inquiries

Please direct all inquiries to:

[email protected] 

Refer to the NOFO for specific research contacts.